Home
About
Overview
Sharing Data
ORCID
Help
History (1)
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study.
STX209 (arbaclofen) for autism spectrum disorders: an 8-week open-label study. J Autism Dev Disord. 2014 Apr; 44(4):958-64.
View in:
PubMed
subject areas
Adolescent
Akathisia, Drug-Induced
Baclofen
Child
Child Development Disorders, Pervasive
Female
GABA-B Receptor Agonists
Humans
Irritable Mood
Male
Treatment Outcome
authors with profiles
Paul Wang